Skip to content

Deal · Acquisition20 October 2026 · Closed

OpenAI acquires Orchestra Bio to add its team to the Rosalind life sciences model

Orchestra makes AI agents that help biotech companies manage drug-discovery operations, and its technology joins the Rosalind Workbench tool.

OpenAI Acquirer · Orchestra Bio Target

The deal

Type
Acquisition
Amount
Not disclosed
Status
Closed
Valuation
Not recorded
Region
United States
Date
20 October 2026

As of this development: a later development may record new terms.

Lifecycle

  1. AnnouncedNot recorded
  2. Closed20 October 2026 · This development

Other acquisitions in Minutes · OpenAI

OpenAI buys Glass Imaging for over $300 million

14 September 2026 · Acquisition · at least $300M · Closed · Glass Imaging

The parties

Orchestra Bio Target

1 development · 1 deal in Minutes

OpenAI Acquirer

14 developments · 2 deals in Minutes

More in Technology

Past 3 months in Activity →